This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

GE to expand in life sciences with buyout of strategic assets from Thermo Fisher Scientific

( January 6, 2014, 14:59 GMT | Official Statement) -- MLex Summary: General Electric announced that its division GE Healthcare will acquire Thermo Fisher’s HyClone cell culture media and sera, as well as gene modulation and magnetic beads businesses for around $1.06 billion. The deal is subject to regulatory approvals and the companies expect to close the transaction in the first part of the year.The full statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login